References
1. Seminara J., Tuchman M., Krivitzky L., et al. Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium. Mol Genet Metab. 2010; 100 (suppl 1): S 97–105.
2. Posset R., Kölker S., Gleich F., et al.; Urea Cycle Disorders Consortium (UCDC) and the European Registry and Network for Intoxication Type Metabolic Diseases (E-IMD) Consortia Study Group. Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders. Mol Genet Metab. 2020; 131 (4): 390–7.
3. Mcmurray W.C., Rathbun J.C., Mohyuddin F., Koegler S.J. Citrullinuria. Pediatrics. 1963; 32: 347–57.
4. Bock H.-G.O., Su T.-S., O’Brien W.E., Beaudet A.L. Sequence for human argininosuccinate synthetase cDNA. Nucleic Acids Res. 1983; 11 (18): 6505–12.
5. Matsumoto S., Häberle J., Kido J., Mitsubuchi H., Endo F., Nakamura K. Urea cycle disorders – update. J Hum Genet. 2019; 64 (9): 833–47.
6. Baranov A.A., Borovik T.E., Bushueva T.V., et al. Violations of the urea formation cycle. Guidelines. In: Union of Pediatricians of Russia. Moscow. 2022: 69 p. (in Russian)
7. Braissant O., McLin V.A., Cudalbu C. Ammonia toxicity to the brain. J Inherit Metab Dis. 2013; 36: 595–612.
8. Bueverov A.O. Ammonia as a neuro- and hepatotoxin: clinical aspects. Meditsinskiy sovet [Medical Council]. 2015; (13): 80–5. (in Russian)
9. Pontoizeau C., Roda C., Arnoux J.B., et al. Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders. Mol Genet Metab. 2020; 130 (2): 110–7.
10. Haeberle J., Boddaert N., Burlina A., Chakrapani A., Dixon M., Huemer M., et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012; 7: 32.
11. Degtyareva A.V., Kirtbaya A.R., Sokolova E.V., et al. Neonatal hyperammonemia transient condition or marker of inborn errors of metabolism? Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2018; 7 (1): 96–102. (in Russian)
12. Butterworth R.F. Effects of hyperammonaemia on brain function. J Inherit Metab Dis. 1998; 21: 6–20.
13. Monfort P., Kosenko E., Erceg S., Canales J.-J., Felipo V. Molecular mechanism of acute ammonia toxicity: role of NMDA receptors. Neurochem Int. 2002; 41 (2–3): 95–102.
14. Golosnaya G.S., Belousova T.N., Novikov M. Yu., et al. Citrullinemia in a newborn: a case report. Russkiy zhurnal detskoy nevrologii [Russian Journal of Child Neurology]. 2022; 17 (3): 72–8. (in Russian)
15. Lin Y., Gao H., Lu B., Zhou S., Zheng T., Lin W., et al. Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS 1: a case report and literature review. BMC Med Genet. 2019; 20 (1): 110.
16. Fernandez-Fructuoso J.R., Gonzalez-Rodriguez J.D., Fuentes-Gutierrez C. Peritoneal dialysis in the emergency management of severe neonatal hyperammonemia secondary to citrullinemia type 1. Ther Apher Dial. 2022; 26 (1): 253–4.
17. Öztürk Z., Hirfanoğlu T., İnci A., Okur İ., Koç E., Tümer L., et al. Citrullinemia with an atypical presentation: paroxysmal hypoventilation attacks. J Pediatr Neurosci. 2018; 13 (2): 276–8.
18. Kehl T.M., Tsiakas K., Mühlhausen C., Santer R., Walter C., von der Wense A., et al. Neonatal metabolic imbalance – hyperventilation in hyperammonemia. Z Geburtshilfe Neonatol. 2014; 218 (6): 269–70.
19. Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog Neurobiol. 2002; 67 (4): 259–79.